Published in Emerg Infect Dis on September 01, 1998
Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev (2005) 14.71
Taxonomy and identification of the Burkholderia cepacia complex. J Clin Microbiol (2001) 4.02
Identification of Burkholderia spp. in the clinical microbiology laboratory: comparison of conventional and molecular methods. J Clin Microbiol (1999) 2.36
Comparative evaluation of the BD Phoenix and VITEK 2 automated instruments for identification of isolates of the Burkholderia cepacia complex. J Clin Microbiol (2002) 2.16
Construction and evaluation of plasmid vectors optimized for constitutive and regulated gene expression in Burkholderia cepacia complex isolates. Appl Environ Microbiol (2002) 2.07
Burkholderia, a genus rich in plant-associated nitrogen fixers with wide environmental and geographic distribution. Appl Environ Microbiol (2001) 1.88
Updated version of the Burkholderia cepacia complex experimental strain panel. J Clin Microbiol (2003) 1.74
An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis (1999) 1.59
Burkholderia cepacia complex bacteria from clinical and environmental sources in Italy: genomovar status and distribution of traits related to virulence and transmissibility. J Clin Microbiol (2002) 1.48
Environmental Burkholderia cepacia complex isolates in human infections. Emerg Infect Dis (2007) 1.36
Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest (2004) 1.18
Identification of quorum-sensing-regulated genes of Burkholderia cepacia. J Bacteriol (2003) 1.10
Outbreak of subclinical mastitis in a flock of dairy sheep associated with Burkholderia cepacia complex infection. J Clin Microbiol (2001) 1.01
Isolation and characterization of antifungal substances from Burkholderia sp. culture broth. Curr Microbiol (2006) 0.94
Commercial use of Burkholderia cepacia. Emerg Infect Dis (1999) 0.91
Insights into β-lactamases from Burkholderia species, two phylogenetically related yet distinct resistance determinants. J Biol Chem (2013) 0.89
Plant-associated symbiotic Burkholderia species lack hallmark strategies required in mammalian pathogenesis. PLoS One (2014) 0.88
Identification and onion pathogenicity of Burkholderia cepacia complex isolates from the onion rhizosphere and onion field soil. Appl Environ Microbiol (2008) 0.87
The complete genome of Burkholderia phenoliruptrix strain BR3459a, a symbiont of Mimosa flocculosa: highlighting the coexistence of symbiotic and pathogenic genes. BMC Genomics (2014) 0.86
Clinical and environmental Burkholderia strains: biofilm production and intracellular survival. Curr Microbiol (2007) 0.86
Bacterial communities in aerosols and manure samples from two different dairies in central and Sonoma valleys of California. PLoS One (2011) 0.83
Garlic revisited: antimicrobial activity of allicin-containing garlic extracts against Burkholderia cepacia complex. PLoS One (2014) 0.80
Global changes in gene expression by the opportunistic pathogen Burkholderia cenocepacia in response to internalization by murine macrophages. BMC Genomics (2012) 0.80
Recent advances in cross-infection in cystic fibrosis: Burkholderia cepacia complex, Pseudomonas aeruginosa, MRSA and Pandoraea spp. J R Soc Med (2003) 0.80
Emergence of Burkholderia cepacia in Honolulu: a case of nursing home-acquired B. cepacia sepsis. Hawaii J Med Public Health (2013) 0.79
Survival and susceptibility of Burkholderia cepacia complex in chlorhexidine gluconate and benzalkonium chloride. J Ind Microbiol Biotechnol (2015) 0.79
Cepacia Syndrome in a Non-Cystic Fibrosis Patient. Case Rep Infect Dis (2015) 0.78
Energy-generating enzymes of Burkholderia cepacia and their interactions with macrophages. J Bacteriol (2003) 0.75
Antimicrobial properties of an oxidizer produced by Burkholderia cenocepacia P525. Curr Microbiol (2014) 0.75
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol Rev (1996) 13.91
Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr (1984) 9.61
Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet (1993) 7.12
Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov. Int J Syst Bacteriol (1997) 5.60
Pseudomonas cepacia colonization in patients with cystic fibrosis: risk factors and clinical outcome. J Pediatr (1985) 4.26
DNA fingerprinting by pulsed field gel electrophoresis and ribotyping to distinguish Pseudomonas cepacia isolates from a nosocomial outbreak. J Clin Microbiol (1991) 4.20
Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol (1996) 4.11
Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med (1994) 3.89
Pseudomonas cepacia colonization among patients with cystic fibrosis. A new opportunist. Am Rev Respir Dis (1985) 3.71
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36
Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis. J Clin Microbiol (1985) 3.09
Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes. Chest (1987) 2.97
Linkage analysis of geographic and clinical clusters in Pseudomonas cepacia infections by multilocus enzyme electrophoresis and ribotyping. J Clin Microbiol (1994) 2.74
Identification and characterization of a novel DNA marker associated with epidemic Burkholderia cepacia strains recovered from patients with cystic fibrosis. J Clin Microbiol (1997) 2.72
Ribotype analysis of Pseudomonas cepacia from cystic fibrosis treatment centers. J Pediatr (1988) 2.60
Physical and genetic mapping of the Rhodobacter sphaeroides 2.4.1 genome: genome size, fragment identification, and gene localization. J Bacteriol (1989) 2.43
Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr (1986) 2.38
Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol (1996) 2.28
Multiple replicons constituting the genome of Pseudomonas cepacia 17616. J Bacteriol (1994) 2.21
Nosocomial Pseudomonas cepacia infection associated with chlorhexidine contamination. Am J Med (1982) 2.14
Pseudomonas cepacia: decrease in colonization in patients with cystic fibrosis. Am Rev Respir Dis (1986) 2.10
Presence of two independent chromosomes in the Brucella melitensis 16M genome. J Bacteriol (1993) 1.83
Presence of one linear and one circular chromosome in the Agrobacterium tumefaciens C58 genome. J Bacteriol (1993) 1.82
Cloning, physical mapping and expression of chromosomal genes specifying degradation of the herbicide 2,4,5-T by Pseudomonas cepacia AC1100. Gene (1988) 1.78
Aqueous quaternary ammonium antiseptics and disinfectants. Use and misuse. JAMA (1976) 1.67
Type characterisation and antibiotic susceptibility of Burkholderia (Pseudomonas) cepacia isolates from patients with cystic fibrosis in the United Kingdom and the Republic of Ireland. J Med Microbiol (1996) 1.60
Pseudomonas cepacia suppression of sunflower wilt fungus and role of antifungal compounds in controlling the disease. Appl Environ Microbiol (1992) 1.41
Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources. J Clin Microbiol (1988) 1.37
Genotypic analysis of Burkholderia cepacia isolates from 13 French cystic fibrosis centers. J Clin Microbiol (1997) 1.29
Pseudomonas cepacia in cystic fibrosis: transmissibility and its implications. Lancet (1993) 1.17
Molecular characterization of rhizosphere and clinical isolates of Burkholderia cepacia. Res Microbiol (1995) 1.11
Foot lesions associated with Pseudomonas cepacia. Lancet (1971) 1.07
The epidemiology of nosocomial Pseudomonas cepacia infections: endemic infections. Eur J Epidemiol (1987) 0.99
Outbreak of Pseudomonas cepacia bacteremia in oncology patients. Clin Infect Dis (1993) 0.95
Lack of evidence of nosocomial cross-infection by Burkholderia cepacia among Danish cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (1996) 0.90
Absence of Burkholderia cepacia from the respiratory tract of non-cystic fibrosis patients. Eur J Clin Microbiol Infect Dis (1997) 0.82
Resolution of recent evolutionary divergence among Escherichia coli from related lineages: the application of pulsed field electrophoresis to molecular epidemiology. J Infect Dis (1990) 8.33
Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. Proc Natl Acad Sci U S A (2001) 7.90
Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2006) 4.80
Transmissibility of Pseudomonas cepacia infection in clinic patients and lung-transplant recipients with cystic fibrosis. N Engl J Med (1994) 3.89
The emergence of a highly transmissible lineage of cbl+ Pseudomonas (Burkholderia) cepacia causing CF centre epidemics in North America and Britain. Nat Med (1995) 3.36
Drinking water turbidity and gastrointestinal illness in the elderly of Philadelphia. J Epidemiol Community Health (2000) 3.15
A Prothrombin Conversion Accelerator in Serum. Science (1949) 2.64
Pseudomonas cepacia typing systems: collaborative study to assess their potential in epidemiologic investigations. Rev Infect Dis (1989) 2.25
Cable (cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J Bacteriol (1995) 2.16
PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosus. J Clin Invest (1999) 2.14
Molecular epidemiology of adhesin and hemolysin virulence factors among uropathogenic Escherichia coli. Infect Immun (1989) 2.12
Restriction fragment length polymorphisms among uropathogenic Escherichia coli isolates: pap-related sequences compared with rrn operons. Infect Immun (1990) 1.95
Interpretation of treatment changes in 6-minute walk distance in patients with COPD. Eur Respir J (2008) 1.82
FK506 trough levels in whole blood and plasma in liver transplant recipients. Correlation with clinical events and side effects. Transplantation (1994) 1.80
Stimulation of human leukocyte thromboplastic activity by endotoxin. Proc Soc Exp Biol Med (1971) 1.79
HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching. Transplantation (1994) 1.71
Composition and dynamics of plasma in Saturn's magnetosphere. Science (2005) 1.66
Skeletal muscle fiber quality in older men and women. Am J Physiol Cell Physiol (2000) 1.66
An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis. J Infect Dis (1999) 1.59
Functional components of basic fibroblast growth factor signaling that inhibit lung elastin gene expression. Am J Physiol Lung Cell Mol Physiol (2001) 1.58
The social context of drinking, drug use, and unsafe sex in the Boston Young Men Study. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.58
Autoantibodies to fibrillarin in systemic sclerosis (scleroderma). An immunogenetic, serologic, and clinical analysis. Arthritis Rheum (1996) 1.54
Racial differences in the frequencies of scleroderma-related autoantibodies. Arthritis Rheum (1992) 1.53
Pneumocystis carinii pneumonia with pleurisy, platypnoea and orthodeoxia. Thorax (2003) 1.53
Childhood sexual abuse among homosexual men. Prevalence and association with unsafe sex. J Gen Intern Med (1997) 1.49
Gender-related differences in thrombogenic factors predicting recurrent cardiac events in patients after acute myocardial infarction. The THROMBO Investigators. Am J Cardiol (2000) 1.47
A randomised trial to evaluate the self-administered standardised chronic respiratory questionnaire. Eur Respir J (2005) 1.46
An emulsion formulation of amphotericin B improves the therapeutic index when treating systemic murine candidiasis. J Infect Dis (1988) 1.43
Lysogenization by satellite phage P4. Virology (1981) 1.43
Sundowning and circadian rhythms in Alzheimer's disease. Am J Psychiatry (2001) 1.40
Conflict resolution at the University of Ottawa Faculty of Medicine: The Pelican and the sign of the triangle. Acad Med (2001) 1.40
Color flow ultrasound for delineating microsurgical vessels: a clinical and experimental study. Ann Plast Surg (1993) 1.40
Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum (1996) 1.39
Lung disease in the cystic fibrosis mouse exposed to bacterial pathogens. Nat Genet (1995) 1.37
Variability of outer membrane protein P1 and its evaluation as a vaccine candidate against experimental otitis media due to nontypeable Haemophilus influenzae: an unambiguous, multifaceted approach. Infect Immun (2000) 1.36
Determination of capsid size by satellite bacteriophage P4. Proc Natl Acad Sci U S A (1978) 1.35
The endogenous eyeblink. Psychophysiology (1984) 1.31
Persistence of human immunodeficiency virus in semen after adding indinavir to combination antiretroviral therapy. Clin Infect Dis (1999) 1.28
Discovery of CGS 27023A, a non-peptidic, potent, and orally active stromelysin inhibitor that blocks cartilage degradation in rabbits. J Med Chem (1997) 1.22
Association of amino acid sequences in the HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scleroderma (progressive systemic sclerosis). J Clin Invest (1992) 1.21
Simultaneous color constancy: paper with diverse Munsell values. J Opt Soc Am A (1991) 1.16
Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Arch Gen Psychiatry (2001) 1.16
In vitro activities of meropenem, PD 127391, PD 131628, ceftazidime, chloramphenicol, co-trimoxazole, and ciprofloxacin against Pseudomonas cepacia. Antimicrob Agents Chemother (1993) 1.15
Mutants of satellite virus P4 that cannot derepress their bacteriophage P2 helper. J Mol Biol (1981) 1.15
Alpha fetoprotein, ultrasound, computerized tomography and magnetic resonance imaging for detection of hepatocellular carcinoma in patients with advanced cirrhosis. Aliment Pharmacol Ther (2007) 1.13
HIV and hepatitis B infection and risk behavior in young gay and bisexual men. Public Health Rep (1997) 1.13
Unsafe sex in men who have sex with both men and women. J Acquir Immune Defic Syndr Hum Retrovirol (1998) 1.12
Association of polar amino acids at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma). J Clin Invest (1992) 1.11
Identification of dipeptidyl nitriles as potent and selective inhibitors of cathepsin B through structure-based drug design. J Med Chem (2001) 1.09
Structure and copy number of gene clusters related to the pap P-adhesin operon of uropathogenic Escherichia coli. Infect Immun (1989) 1.09
Burkholderia (Pseudomonas) cepacia as a cause of brain abscesses secondary to chronic suppurative otitis media. Eur J Clin Microbiol Infect Dis (1995) 1.09
Effect of luminance on suprathreshold contrast perception. J Opt Soc Am A (1991) 1.09
Simultaneous constancy, lightness, and brightness. J Opt Soc Am A (1987) 1.06
A review of the results of laparoscopic versus open appendectomy. Surg Gynecol Obstet (1993) 1.03
Viral interference at the level of capsid size determination by satellite phage P4. J Mol Biol (1978) 1.02
Middle component averaged electroencephalic responses to tonal stimuli from normal neonates. Initial report. Arch Otolaryngol (1978) 1.02
Oral theophylline for chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2002) 1.01
Propagation of satellite phage P4 as a plasmid. Proc Natl Acad Sci U S A (1982) 1.01
Transcriptional control of capsid size in the P2:P4 bacteriophage system. J Mol Biol (1978) 0.99
X-ray inactivation of bacteriophages: role of O 2 -dependent damage in single- and double-strand DNA phages. Virology (1972) 0.98
Psychiatric disorders and impairment in the children of opiate addicts: prevalances and distribution by ethnicity. Am J Addict (2000) 0.98
Lightness models, gradient illusions, and curl. Percept Psychophys (1987) 0.97
Regulation of icosahedral virion capsid size by the in vivo activity of a cloned gene product. Proc Natl Acad Sci U S A (1990) 0.97
Physical study of prophage excision and curing of lambda prophage from lysogenic Escherichia coli. J Mol Biol (1973) 0.96
Canadian prediction equations of spirometric lung function for Caucasian adults 20 to 90 years of age: results from the Canadian Obstructive Lung Disease (COLD) study and the Lung Health Canadian Environment (LHCE) study. Can Respir J (2011) 0.96
Head size determination and the morphogenesis of satellite phage P4. Curr Top Microbiol Immunol (1974) 0.94
Liver and kidney transplantation for polycystic disease. Transplantation (1998) 0.94
Anti-ribosomal P antibodies in systemic lupus erythematosus: a case-control study correlating hepatic and renal disease. Clin Immunol Immunopathol (1995) 0.94
Regular versus as-needed short-acting inhaled beta-agonist therapy for chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2001) 0.94
De novo malignancy following liver transplantation: a single-center study. Transplant Proc (1993) 0.93
HPRT- mutant T cells in the peripheral blood and synovial tissue of patients with rheumatoid arthritis. Arthritis Rheum (1998) 0.93
Capsid structure of satellite phage P4 and its P2 helper. J Ultrastruct Res (1982) 0.93
Loss of serum antibodies to a conformational epitope of HIV-1/gp120 identified by a human monoclonal antibody is associated with disease progression. J Acquir Immune Defic Syndr (1993) 0.92
Minimal incidence of serum antibodies reactive with intact primary isolate virions in human immunodeficiency virus type 1-infected individuals. J Virol (1999) 0.92
Attention to television: intrastimulus effects of movement and scene changes on alpha variation over time. Int J Neurosci (1985) 0.92
In vitro and in vivo reactivity and specificity of fractions from sonicates of Mycobacterium tuberculosis separated by gradient acrylamide gel electrophoresis. Am Rev Respir Dis (1980) 0.92
Tympanometric and acoustic-reflex studies in neonates. J Speech Hear Res (1985) 0.92
In vitro synthesis of IgM rheumatoid factor in response to Staphylococcus aureus, by lymphocytes from healthy adults. Arthritis Rheum (1986) 0.92
Effects of orthotopic liver transplantation and immunosuppression on inflammatory bowel disease in primary sclerosing cholangitis patients. Transplant Proc (1993) 0.91
Congenital lipomatosis of the pancreas. Malabsorption, dwarfism, leukopenia with relative granulocytopenia and thrombocytopenia. Clin Pediatr (Phila) (1968) 0.91
The centromere kinesin-like protein, CENP-E. An autoantigen in systemic sclerosis. Arthritis Rheum (1996) 0.91
A comparison of chronic pain patients and controls on traumatic events in childhood. Disabil Rehabil (2000) 0.90
Site of lesion in cases of hearing loss associated with Rh incompatibility: an argument for peripheral impairment. J Speech Hear Disord (1972) 0.90
C4A gene deletion and HLA associations in black Americans with systemic lupus erythematosus. Immunogenetics (1989) 0.90
Metastatic calcification of the stomach imaged on a bone scan. Clin Nucl Med (1984) 0.90
Placebo effects in oral triptan trials: the scientific and ethical rationale for continued use of placebo controls. Cephalalgia (2005) 0.90
Pediatric esophageal perforation. J Thorac Cardiovasc Surg (1977) 0.89
Clinical correlates, serum autoantibodies and the role of the major histocompatibility complex in French Canadian and non-French Canadian Caucasians with SLE. Lupus (1998) 0.89
Long-term follow-up review of 31 children with severe closed head trauma. J Neurosurg (1990) 0.88
Distribution of serotonin-immunoreactivity in juvenile Aplysia. Neuroscience (1984) 0.88
Natural history of fetal ventriculomegaly. Pediatrics (1988) 0.88
Chemosensitization of human hepatocellular carcinoma cells with cyclosporin A in post-liver transplant patient plasma. Clin Cancer Res (1996) 0.88
Intentional injury surveillance in a primary care pediatric setting. Arch Pediatr Adolesc Med (1996) 0.87
Early components of the averaged electroencephalic response to constant level clicks during all-night sleep. J Speech Hear Res (1971) 0.87
Growth failure due to protein loss in dermatitis. Eur J Pediatr (1986) 0.87
Gold sodium thiomalate compared to low dose methotrexate in the treatment of rheumatoid arthritis--a randomized, double blind 26-week trial. J Rheumatol (1989) 0.86
Long-term behavioral and electrophysiological changes associated with lead exposure at different stages of brain development in the rat. Brain Res (1986) 0.86
Efficacy of theophylline in people with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. Respir Med (2005) 0.86
Early-onset autoimmune hepatitis is associated with a C4A gene deletion. Gastroenterology (1993) 0.86
Problems and complications encountered in replantation surgery. Hand Clin (1986) 0.86